#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4807192	F	Inverse agonist activity at human GPR174 expressed in cells assessed as inhibition of CRE-luc reporter activity by measuring decrease in Gs-protein signalling activity relative to control	Homo sapiens	50		cell-based format	Patent Bioactivity Data
2.	ALA4807193	F	Inhibition of GPR174 (unknown origin) in cells assessed as incorporation of nuclear localization sequence into transmembrane protein by cellular redistribution assay	Homo sapiens	26		assay format	Patent Bioactivity Data
3.	ALA4807194	F	Inverse agonist activity at human GPR174 expressed in cells assessed as inhibition of CRE-luc reporter activity by measuring decrease in Gs-protein signalling activity	Homo sapiens	50		cell-based format	Patent Bioactivity Data
4.	ALA4807241	F	Induction of TNF production in anti-CD3/CD28-stimulated human PBMCs assessed as fold increase in TNF level at 1 uM after 24 hrs by ELISA	Homo sapiens	4		tissue-based format	Patent Bioactivity Data
5.	ALA4807244	F	Induction of IL-2 production in anti-CD3/CD28-stimulated human PBMCs assessed as fold increase in IL-2 level at 1 uM after 24 hrs by ELISA	Homo sapiens	4		tissue-based format	Patent Bioactivity Data
6.	ALA4807247	F	Induction of INF-gamma production in anti-CD3/CD28-stimulated human PBMCs assessed as fold increase in INF-gamma level at 1 uM after 24 hrs by ELISA	Homo sapiens	4		tissue-based format	Patent Bioactivity Data
7.	ALA4807261	F	Antagonist activity at GPR174 (unknown origin) expressed in HEK293 cells assessed as inhibition of PS-induced GPR174 signaling incubated for 15 mins by GloSensor assay	Homo sapiens	7		cell-based format	Patent Bioactivity Data
8.	ALA4807278	F	Inverse agonist activity at human GPR174 by CRA	Homo sapiens	51		assay format	Patent Bioactivity Data
9.	ALA4807279	F	Inverse agonist activity at human GPR174 assessed as fold decrease in Gs signalling activity by CRA	Homo sapiens	51		assay format	Patent Bioactivity Data
10.	ALA4807311	F	Induction of INF-gamma production in anti-CD3/CD28-stimulated human PBMCs assessed as fold increase in INF-gamma level at 0.3 uM after 24 hrs by ELISA	Homo sapiens	3		tissue-based format	Patent Bioactivity Data
11.	ALA4807314	F	Induction of INF-gamma production in anti-CD3/CD28-stimulated human PBMCs assessed as fold increase in INF-gamma level at 1 uM after 24 hrs in presence of 0.1 uM A2aR inhibitor ZM-241385 by ELISA	Homo sapiens	3		tissue-based format	Patent Bioactivity Data
12.	ALA4807315	F	Induction of INF-gamma production in anti-CD3/CD28-stimulated human PBMCs assessed as fold increase in INF-gamma level at 0.3 uM after 24 hrs in presence of 0.1 uM A2aR inhibitor ZM-241385 by ELISA	Homo sapiens	3		tissue-based format	Patent Bioactivity Data
13.	ALA4807319	F	Induction of IL-2 production in anti-CD3/CD28-stimulated human PBMCs assessed as fold increase in IL-2 level at 0.3 uM after 24 hrs by ELISA	Homo sapiens	3		tissue-based format	Patent Bioactivity Data
14.	ALA4807322	F	Induction of IL-2 production in anti-CD3/CD28-stimulated human PBMCs assessed as fold increase in IL-2 level at 1 uM after 24 hrs in presence of 0.1 uM A2aR inhibitor ZM-241385 by ELISA	Homo sapiens	3		tissue-based format	Patent Bioactivity Data
15.	ALA4807323	F	Induction of IL-2 production in anti-CD3/CD28-stimulated human PBMCs assessed as fold increase in IL-2 level at 0.3 uM after 24 hrs in presence of 0.1 uM of A2aR inhibitor ZM-241385 by ELISA	Homo sapiens	3		tissue-based format	Patent Bioactivity Data
16.	ALA4807327	F	Induction of TNF production in anti-CD3/CD28-stimulated human PBMCs assessed as fold increase in TNF level at 0.3 uM after 24 hrs by ELISA	Homo sapiens	3		tissue-based format	Patent Bioactivity Data
17.	ALA4807330	F	Induction of TNF production in anti-CD3/CD28-stimulated human PBMCs assessed as fold increase in TNF level at 1 uM after 24 hrs in presence of 0.1 uM of A2aR inhibitor ZM-241385 by ELISA	Homo sapiens	3		tissue-based format	Patent Bioactivity Data
18.	ALA4807331	F	Induction of TNF production in anti-CD3/CD28-stimulated human PBMCs assessed as fold increase in TNF level at 0.3 uM after 24 hrs in presence of 0.1 uM of A2aR inhibitor ZM-241385 by ELISA	Homo sapiens	3		tissue-based format	Patent Bioactivity Data
19.	ALA4807335	F	Induction of GM-CSF production in anti-CD3/CD28-stimulated human PBMCs assessed as fold increase in GM-CSF level at 1 uM after 24 hrs by ELISA	Homo sapiens	3		tissue-based format	Patent Bioactivity Data
20.	ALA4807336	F	Induction of GM-CSF production in anti-CD3/CD28-stimulated human PBMCs assessed as fold increase in GM-CSF level at 0.3 uM after 24 hrs by ELISA	Homo sapiens	3		tissue-based format	Patent Bioactivity Data